Law Enforcement and Pain Management

Duration: 60 Minutes
Instructor: Carlos M. Aquino
Webinar Id: 800156


One Attendee


Class participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II though V controlled substances that are dispensed, or prescribed by a physician as part of a pain treatment plan. Also they will be familiarized with the necessary documentation that should be noted in the patient chart and step to prevent diversion of the dispensed or prescribed drugs.

Why should you attend: As a pain management clinic or physician treating pain, you are required by federal and state laws and regulations to take many steps in order to be assured that the controlled substance you dispensed or prescribed are done with a legitimate medical purpose and are being properly used by the patient. This training will cover steps that will assist you in order to comply with these laws and regulations. The topics are focused on the patient-doctor relationship and the necessary information that is need in a patient chart that may result in a prescription for pain. The training will also provide you with a better understanding of DEA and their record keeping and security requirements.

Areas Covered in the Session:

  • Describe the types of actions that can be imposed by a federal prosecutor's office on a pain management clinic or a physician treating pain. This includes the type of fines that can be imposed through a criminal or civil action utilizing the federal laws and regulations pertaining to the administering, dispensing, and prescribing of controlled substances as part of a pain management treatment plan.
  • Identify the steps taken by the DEA in enforcing federal laws and regulations through their Office of Diversion Control who is responsible for all investigation and regulatory actions for Schedules II through V controlled substance especially those dispensed or prescribed as part of a pain management treatment plan.
  • Discuss the importance of a good patient chart that contains all documentation beginning when the patient was initially accepted as a patient to the most recent visit to the clinic or seen by the physician. This includes the patient agreement, the treatment plan, and any controlled substance administered, dispensed or prescribed for the patient.
  • Review all the requirements pertaining to administering, dispensing and prescribing of controlled substance prescription by a physician as part of a pain management treatment plan. The subjects covered will also include electronic prescriptions, the DEA regulation pertaining to a 90-day supply of a Schedule II drug, and prescriptions written for opioid dependency patients.

Who Will Benefit:
  • Compliance Managers
  • Quality Managers
  • DEA Professionals
  • Manufacturers
  • Pain Management
  • Physicians

CME Credit Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Colorado Foundation for Medical Care (CFMC) and MentorHealth. CFMC is accredited by the ACCME to provide continuing medical education for physicians.

Colorado Foundation for Medical Care designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals Credit Statement
This educational activity has been planned and implemented following the administrative and educational design criteria required for certification of health care professions continuing education credits. Registrants attending this activity may submit their certificate along with a copy of the course content to their professional organizations or state licensing agencies for recognition for 1 hour.

Disclosure Statement
It is the policy of Colorado Foundation for Medical Care (CFMC) and MentorHealth that the faculty discloses real or apparent conflicts of interest relating to the topics of the educational activity. All members of the faculty and planning team have nothing to disclose nor do they have any vested interests or affiliations.

Obtaining Certificate of Credit

Colorado Foundation for Medical Care (CFMC) hosts an online activity evaluation system, certificate and outcomes measurement process. Following the activity, you must link to CFMC’s online site (link below) to complete the evaluation form in order to receive your certificate of credit. Once the evaluation form is complete and submitted, you will be automatically sent a copy of your certificate via email. Please note, participants must attend the entire activity to receive all types of credit. Continuing Education evaluation and request for certificates will be accepted up to 60 days post activity date. CFMC will keep a record of attendance on file for 6 years.

Speaker Profile
Carlos M. Aquino brings 36 years of experience of handling illicit and pharmaceutical controlled substances and regulated chemicals. His testimonial ability, both in federal and state courts, is proof of his investigative experience and skills. Carlos has 12 years of experience working for Philadelphia DEA Diversion Group, which is responsible for initiating prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. This has included eight years as a Diversion Investigator and four years as a Group Supervisor. During his time at the DEA, he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals.

In addition to the above, Carlos has over 20 years of experience working for various law enforcement agencies including the Philadelphia Police. Carlos has a BA in Criminal Justice and has taught numerous courses during his time at the DEA.

He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.

You Recently Viewed